Multi-Component Formulation for Alzheimer's Neuroprotection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Alzheimer's disease and cognitive decline are ineffective, as they fail to address the multifactorial nature of the condition, and no comprehensive medicine or protocol has emerged to manage the degenerative and complex pathologic characteristics of Alzheimer's, which include inflammation, oxidative stress, and impaired cerebral blood flow, affecting millions of patients worldwide.
Innovation Solution
A multi-component formulation comprising methylsulfonylmethane, fructose 1,6-diphosphate, and at least one of trehalose, green tea extract, ashwagandha, and rutin is administered to patients, which helps in preventing, delaying, and treating cognitive decline by addressing the multiple contributing factors of Alzheimer's disease, promoting neuroprotection and restoring balance in the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for Alzheimer's disease are used, then they are simple in composition, but they are ineffective in addressing the multifactorial nature of the condition
Solution Approach 1:
The patent combines multiple active ingredients (methylsulfonylmethane, fructose 1,6-diphosphate, and at least one of trehalose, green tea extract, ashwagandha, or rutin) into a single multi-component formulation. This merging of multiple substances addresses the multifactorial nature of Alzheimer's disease by simultaneously targeting inflammation, oxidative stress, and other pathologic characteristics, thereby improving effectiveness while maintaining ease of administration.
Solution Approach 2:
The invention creates a composite pharmaceutical formulation comprising multiple distinct compounds with different mechanisms of action. This composite approach allows the treatment to address multiple contributing factors to Alzheimer's disease (inflammation, oxidative stress, impaired cerebral blood flow) simultaneously, resolving the contradiction between treatment simplicity and effectiveness.
2Adaptability or versatility
If a comprehensive medicine for Alzheimer's is developed, then it can address multiple contributing factors, but no such medicine has emerged yet
Solution Approach 1:
The multi-component formulation is designed to perform multiple functions simultaneously: methylsulfonylmethane addresses inflammation, fructose 1,6-diphosphate targets oxidative stress and energy metabolism, and the additional components (trehalose, green tea extract, ashwagandha, or rutin) provide complementary neuroprotective effects. This multi-functional design enables a single formulation to address the diverse pathologic characteristics of Alzheimer's disease, achieving both versatility and proven efficacy.
3Ease of operation
If single-component treatments are used, then they are easy to administer, but they fail to address the complex pathologic characteristics of Alzheimer's
Solution Approach 1:
The patent merges multiple active ingredients into a single combined formulation that can be administered through a single dose. This approach maintains the ease of single-administration while incorporating multiple compounds that collectively address inflammation, oxidative stress, and other pathologic characteristics of Alzheimer's disease, thereby resolving the contradiction between administration simplicity and treatment effectiveness.
Data Source
AI summary
Multi-component formulations comprise methylsulfonylmethane, fructose 1,6-diphosphate, and just one of trehalose, green tea extract, ashwagandha, and rutin, or a combination thereof. Multi-component formulations can prevent, delay, or treat cognitive decline, Alzheimer's disease, and other dementias.